Ignite Creation Date:
2024-06-16 @ 11:51 AM
Last Modification Date:
2024-10-26 @ 3:32 PM
Study NCT ID:
NCT06459245
Status:
ENROLLING_BY_INVITATION
Last Update Posted:
2024-07-03
First Post:
2024-06-10
Brief Title:
Resistance Training to Prevent Lymphedema After Breast Cancer Surgery Randomized Controlled Study
Sponsor:
Yue WANG
Organization:
Peking University First Hospital
Study Overview
Official Title:
Resistance Training to Prevent Lymphedema After Breast Cancer Surgery Randomized Controlled Study
Status:
ENROLLING_BY_INVITATION
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Breast cancer-related lymphedema is one of the most common chronic complications of breast cancer survivors In existing studies the reported incidence of lymphedema ranges from 25 to 429 At present there is no cure for lymphedema Resistance training has been proved by many studies to alleviate the symptoms of lymphedema improve the muscle strength of the upper limbs of patients and improve the quality of life of patients while not worsening lymphedema Based on the best evidence this study intends to construct resistance appropriate for this clinical scenario Training program Conduct 3-month intervention for patients after breast cancer surgery to explore the effect of resistance training on the grip strength of the affected limb the range of motion of the shoulder joint of the affected limb the occurrence of lymphedema of the affected limb quality of life etc
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None